+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene



Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene



Gene Therapy 9(1): 12-20



Osteoarthritis in horses and in humans is a significant social and economic problem and continued research and improvements in therapy are needed. Because horses have naturally occurring osteoarthritis, which is similar to that of humans, the horse was chosen as a species with which to investigate gene transfer as a potential therapeutic modality for the clinical treatment of osteoarthritis. Using an established model of equine osteoarthritis that mimics clinical osteoarthritis, the therapeutic effects resulting from intra-articular overexpression of the equine interleukin-1 receptor antagonist gene through adenoviral-mediated gene transfer were investigated. In vivo delivery of the equine IL-IRa gene led to elevated intra-articular expression of interleukin-1 receptor antagonist for approximately 28 days, resulting in significant improvement in clinical parameters of pain and disease activity, preservation of articular cartilage, and beneficial effects on the histologic parameters of synovial membrane and articular cartilage. Based on these findings, gene transfer of interleukin-1 receptor antagonist is an attractive treatment modality for the equine patient and also offers future promise for human patients with osteoarthritis.

Accession: 003993130

Download citation: RISBibTeXText

PMID: 11850718

DOI: 10.1038/sj.gt.3301608


Related references

Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model. Human Gene Therapy. Clinical Development 29(2): 90-100, 2018

Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment. Journal of Gene Medicine 20(5): E3021, 2018

In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis and Rheumatism 40(6): 1012-1019, 1997

Evaluation of topical diclofenac liposomal cream for treatment of equine osteoarthritis using an equine experimental model. 2007

Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. Journal of Orthopaedic Research 22(4): 742-750, 2004

Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model. Human Gene Therapy. Clinical Development 29(2): 101-112, 2018

Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1 beta. American Journal of Veterinary Research 66(11): 1861-1869, 2005

Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy. Zhonghua Yi Xue Za Zhi 84(10): 853-856, 2004

Treatment of equine joint diseases. Part 1: Pharmacological management of equine osteoarthritis (OA). UK Vet: Companion Animal 12(4): 9-15, 2007

In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. American Journal of Pathology 154(4): 1159-1169, 1999

Treatment of equine joint diseases. Part 2: Surgical and physical treatment of equine osteoarthritis. UK Vet: Companion Animal 12(8): 10-15, 2007

Characterization of 41 CD49d/CD29 on Equine Leukocytes Potential Utility of a Potent41 CD49d/CD29 Receptor Antagonist in the Treatment of Equine Heaves Recurrent Airway Obstruction. 2009

Molecular cloning and mRNA expression of equine interleukin-1 receptor antagonist. Animal Genetics 27(SUPPL 2): 51, 1996

Molecular cloning and functional expression of equine interleukin-1 receptor antagonist. Veterinary Immunology & Immunopathology 56(3-4): 221-231, 1997

Interleukin-1 gene expression in equine granulosa cells and effect of IL-1beta on the in vitro nuclear maturation of equine oocytes. Journal of Reproduction & Fertility Abstract Series (26): 14, 2000